Patent details

Basic Information

Publication number:

EP2240466

PCT Application Number:

PCT/GB/2009/000041

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097005797

PCT Publication Number:

WO/2009/087381

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-Ö(3S)-PIPERIDIN-3- YLÜPHENYL} -2H-INDAZOLE-7-CARBOXAMIDE

French Title of Invention:

SELS PHARMACEUTIQUEMENT ACCEPTABLES DE 2-{4-Ö(3S)-PIPÉRIDIN-3-YLÜPHÉNYL}-2H-INDAZOLE-7-CARBOXAMIDE

German Title of Invention:

PHARMAZEUTISCH AKZEPTABLE SALZE VON 2-{4-?(3S)-PIPERIDIN-3- ÖLÜPHENYL} -2H-INDAZOL-7-CARBOXAMID

SPC Number:

Dates

Filing date:

08/01/2009

Grant date:

29/07/2015

EP Publication Date:

29/07/2015

PCT Publication Date:

16/07/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/10/2010

EP B1 Publication Date:

29/07/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/01/2016

Expiration date:

08/01/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/01/2009

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Name:

Merck Sharp & Dohme Limited

Address:

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom (GB)

Inventor

1

Name:

WILSON Robert, Darrin

Address:

United Kingdom (GB)

2

Name:

FOLEY Jennifer, R.

Address:

United States (US)

Priority

Priority Number:

10333

Priority Date:

08/01/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 401/10;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages